MITOCHONDRIAL-DNA MUTATIONS IN HUMAN DEGENERATIVE DISEASES AND AGING
MITOCHONDRIAL-DNA MUTATIONS IN HUMAN DEGENERATIVE DISEASES AND AGING
复制标题
DOI：
10.1016/0925-4439(95)00021-u
复制
发表时间：
1995-05-24
影响因子：
6.2
通讯作者：
LOTT, MT
中科院分区：
文献类型：
--
作者：
WALLACE, DC;SHOFFNER, JM;LOTT, MT
最近在脑、心脏、骨骼肌、肾脏和内分泌系统的退行性疾病中发现了各种各样的线粒体DNA(MtDNA)突变。一般来说，遗传这些线粒体疾病的人在早期生活中相对正常，在童年、中年或老年出现症状，这取决于母亲遗传的mtDNA突变的严重程度；然后经历一个渐进的下降。线粒体DNA病的这些新特征被认为是靶器官对线粒体生物能量学的高度依赖、遗传mtDNA突变导致的累积氧化磷酸化(OXPHOS)缺陷以及有丝分裂后组织中与年龄相关的mtDNA突变积累的产物。
A wide variety of mitochondrial DNA (mtDNA) mutations have recently been identified in degenerative diseases of the brain, heart, skeletal muscle, kidney and endocrine system. Generally, individuals inheriting these mitochondrial diseases are relatively normal in early life, develop symptoms during childhood, mid-life, or old age depending on the severity of the maternally-inherited mtDNA mutation; and then undergo a progressive decline. These novel features of mtDNA disease are proposed to be the product of the high dependence of the target organs on mitochondrial bioenergetics, and the cumulative oxidative phosphorylation (OXPHOS) defect caused by the inherited mtDNA mutation together with the age-related accumulation mtDNA mutations in post-mitotic tissues.